Naftifine-analogues as anti-Trypanosoma cruzi agents
Authors:
- Lucía BoianiLBLucía Boiani
- Paola HernándezPHPaola Hernández
- Maximiliano SortinoMSMaximiliano Sortino
- Susana ZacchinoSZSusana Zacchino
- Mercedes GonzálezMGMercedes González
- Hugo CerecettoHCHugo Cerecetto
- 1 June 2010
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 45 (6) , 2154-2164
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Neglected Tropical Diseases: Multi-Target-Directed Ligands in the Search for Novel Lead Candidates against Trypanosoma and LeishmaniaJournal of Medicinal Chemistry, 2009
- The future of Chagas disease controlTrends in Parasitology, 2006
- Comparative Genomics of Trypanosomatid Parasitic ProtozoaScience, 2005
- Specific chemotherapy of Chagas disease: controversies and advancesTrends in Parasitology, 2003
- Current treatment approaches to leishmaniasisCurrent Opinion in Infectious Diseases, 2003
- Oxidosqualene Cyclase Inhibitors as Antimicrobial AgentsJournal of Medicinal Chemistry, 2003
- New chemotherapeutic approaches for the treatment of Chagas disease (American Trypanosomiasis)Expert Opinion on Therapeutic Patents, 2003
- Chemotherapy of Chagas Disease: Status and New DevelopmentsCurrent Topics in Medicinal Chemistry, 2002
- The impact of Chagas disease control in Latin America: a reviewMemórias do Instituto Oswaldo Cruz, 2002
- Chemotherapy of Chagas DiseaseCurrent Pharmaceutical Design, 2002